Abound Wealth Management Laboratory Corp Of America Holdings Transaction History

Abound Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 08, 2024	BUY	$209.01 - $232.56 $2,717 - $3,023	13 Added 14.77%	101 $22 Million
Q4 2023 Aug 08, 2024	BUY	$197.69 - $227.29 $12,059 - $13,864	61 Added 225.93%	88 $20 Million
Q3 2023 Aug 08, 2024	SELL	$201.05 - $221.7 $1,407 - $1,551	-7 Reduced 20.59%	27 $5.44 Million
Q2 2023 Aug 08, 2024	BUY	$211.93 - $241.33 $1,907 - $2,171	9 Added 36.0%	34 $8.21 Million
Q1 2023 Aug 07, 2024	BUY	$213.32 - $257.83 $5,333 - $6,445	25 New	25 $5.74 Million
Q4 2022 Aug 07, 2024	BUY	$203.72 - $248.97 $2,240 - $2,738	11 Added 220.0%	16 $3.77 Million
Q3 2022 Aug 07, 2024	SELL	$204.81 - $262.19 $4,096 - $5,243	-20 Reduced 80.0%	5 $1.03 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Abound Wealth Management with notifications on news.